Clinicopathological significance and potential drug target of T-cadherin in NSCLC

BACKGROUND: Previous studies demonstrate that T-cadherin is a candidate tumor suppressor in several types of human tumors, including non-small cell lung cancer (NSCLC). Lack of protein expression of T-cadherin by hypermethylation has been found to play an important role in lung alveolar differentiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhidong, Wang, Bin, Guo, Huanchen, Shi, Guoyu, Hong, Xiuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278732/
https://www.ncbi.nlm.nih.gov/pubmed/25565774
http://dx.doi.org/10.2147/DDDT.S74259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278732/
https://www.ncbi.nlm.nih.gov/pubmed/25565774
http://dx.doi.org/10.2147/DDDT.S74259

Ejemplares similares